Synthesis of water-soluble, branched polysaccharides having D-mannopyranose, D-arabinofuranose, or oligo-D-arabinofuranose side-chains and their antitumor activity. 1986

K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki

Branched polysaccharides having D-mannopyranose, D-arabinofuranose, or oligo-D-arabinofuranose side-chains were synthesized by the reaction of 3,4,6-tri-O-acetyl-(1,2-O-ethylorthoacetyl)-beta-D-mannopyranose, 3,5-di-O-benzoyl-(1,2-O-ethylorthobenzoyl)-beta-D-arabinofuranose, or 3-O-benzoyl-(1,2,5-O-orthobenzoyl)-beta-D-arabinofuranose with cellulose acetate or curdlan acetate, followed by desterification. The structure and antitumor activity of the water-soluble portion of the polysaccharides thus obtained were investigated. Polysaccharides synthesized from (1----3)-beta-D-glucan as the main chain with oligo-D-arabinofuranose side-chains exhibited high antitumor activity.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008358 Mannose A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. (From Grant & Hackh's Chemical Dictionary, 5th ed & Random House Unabridged Dictionary, 2d ed) D-Mannose,Mannopyranose,Mannopyranoside,D Mannose
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D002236 Carbohydrate Conformation The characteristic 3-dimensional shape of a carbohydrate. Carbohydrate Linkage,Carbohydrate Conformations,Carbohydrate Linkages,Conformation, Carbohydrate,Conformations, Carbohydrate,Linkage, Carbohydrate,Linkages, Carbohydrate
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001089 Arabinose L-Arabinose,L Arabinose

Related Publications

K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
February 1972, Angewandte Chemie (International ed. in English),
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
July 2013, The Journal of steroid biochemistry and molecular biology,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
June 2004, Bioorganic & medicinal chemistry letters,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
March 2017, MedChemComm,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
December 2002, International journal of biological macromolecules,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
March 1979, Journal of medicinal chemistry,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
October 1999, Bioorganic & medicinal chemistry letters,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
June 2011, Biomacromolecules,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
September 1999, Bioorganic & medicinal chemistry letters,
K Matsuzaki, and T Sato, and K Enomoto, and I Yamamoto, and R Oshima, and K Hatanaka, and T Uryu, and H Kaku, and Y Sone, and A Misaki
August 2016, Angewandte Chemie (International ed. in English),
Copied contents to your clipboard!